Financials Nutrien Ltd.

Equities

NTR

CA67077M1086

Agricultural Chemicals

Market Closed - Toronto S.E. 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
71.83 CAD +1.00% Intraday chart for Nutrien Ltd. -1.01% -3.78%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27,400 27,364 42,922 37,922 27,847 25,952 - -
Enterprise Value (EV) 1 37,833 36,130 53,269 48,949 39,472 36,206 36,023 35,923
P/E ratio 28.1 x 59.4 x 13.6 x 5.14 x 22.3 x 13.9 x 13.2 x 15.2 x
Yield 3.68% 3.87% 2.45% 2.63% 3.76% 4.08% 4.21% 4.36%
Capitalization / Revenue 1.42 x 1.36 x 1.6 x 1.02 x 0.99 x 0.96 x 0.94 x 0.9 x
EV / Revenue 1.96 x 1.8 x 1.98 x 1.32 x 1.41 x 1.33 x 1.31 x 1.25 x
EV / EBITDA 9.4 x 9.85 x 7.48 x 4.02 x 6.52 x 6.46 x 6.28 x 6.36 x
EV / FCF 19.5 x 19 x 25.3 x 8.63 x 16.5 x 16.2 x 15.5 x 17.1 x
FCF Yield 5.12% 5.26% 3.95% 11.6% 6.07% 6.16% 6.46% 5.84%
Price to Book 1.2 x 1.22 x 1.77 x 1.43 x 1.11 x 1.02 x 0.99 x 0.98 x
Nbr of stocks (in thousands) 5,72,900 5,69,146 5,70,786 5,20,184 4,94,547 4,94,589 - -
Reference price 2 47.83 48.08 75.20 72.90 56.31 52.47 52.47 52.47
Announcement Date 18/02/20 17/02/21 16/02/22 15/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 19,255 20,053 26,861 37,012 28,082 27,121 27,540 28,684
EBITDA 1 4,025 3,667 7,126 12,170 6,058 5,601 5,738 5,646
EBIT 1 1,862 902 4,781 10,809 2,745 3,457 3,443 3,141
Operating Margin 9.67% 4.5% 17.8% 29.2% 9.77% 12.75% 12.5% 10.95%
Earnings before Tax (EBT) 1 1,308 382 4,168 10,246 1,952 2,494 2,603 2,341
Net income 1 992 459 3,153 7,660 1,258 2,062 2,108 1,898
Net margin 5.15% 2.29% 11.74% 20.7% 4.48% 7.6% 7.66% 6.62%
EPS 2 1.700 0.8100 5.520 14.18 2.530 3.779 3.974 3.460
Free Cash Flow 1 1,937 1,900 2,103 5,672 2,395 2,229 2,326 2,098
FCF margin 10.06% 9.47% 7.83% 15.32% 8.53% 8.22% 8.44% 7.32%
FCF Conversion (EBITDA) 48.12% 51.81% 29.51% 46.61% 39.53% 39.8% 40.53% 37.16%
FCF Conversion (Net income) 195.26% 413.94% 66.7% 74.05% 190.38% 108.1% 110.31% 110.56%
Dividend per Share 2 1.760 1.860 1.840 1.920 2.120 2.141 2.208 2.287
Announcement Date 18/02/20 17/02/21 16/02/22 15/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 5,804 7,069 7,454 14,285 7,984 7,289 5,908 11,402 5,368 5,404 5,184 10,693 5,465 5,374 5,140
EBITDA 1 1,642 2,463 2,615 4,993 2,467 2,095 1,421 2,478 1,084 1,075 981.5 2,226 1,187 1,231 947.7
EBIT 1 1,057 1,827 1,999 4,945 2,206 1,659 939 1,128 385 293 492.3 1,677 678.5 690.7 319.5
Operating Margin 18.21% 25.85% 26.82% 34.62% 27.63% 22.76% 15.89% 9.89% 7.17% 5.42% 9.5% 15.68% 12.42% 12.85% 6.22%
Earnings before Tax (EBT) 1 935 1,581 1,890 4,815 2,070 1,471 769 924 179 80 296.3 1,483 495.3 478 127
Net income 1 717 1,201 1,378 3,593 1,577 1,112 571 440 75 172 214.1 1,100 367.3 357.1 96.5
Net margin 12.35% 16.99% 18.49% 25.15% 19.75% 15.26% 9.66% 3.86% 1.4% 3.18% 4.13% 10.28% 6.72% 6.65% 1.88%
EPS 2 1.250 2.110 2.490 6.510 2.940 2.150 1.140 0.8900 0.1500 0.3500 0.4020 2.156 0.7980 0.7640 0.2050
Dividend per Share 2 0.4600 0.4600 0.4800 0.4800 0.4600 0.5000 0.5300 0.5300 0.5300 0.5300 0.5266 0.5291 0.5291 0.5291 0.5347
Announcement Date 01/11/21 16/02/22 02/05/22 03/08/22 02/11/22 15/02/23 10/05/23 02/08/23 01/11/23 21/02/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 10,433 8,766 10,347 11,027 11,625 10,254 10,071 9,972
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.592 x 2.391 x 1.452 x 0.9061 x 1.919 x 1.831 x 1.755 x 1.766 x
Free Cash Flow 1 1,937 1,900 2,103 5,672 2,395 2,229 2,326 2,099
ROE (net income / shareholders' equity) 5.36% 4.54% 13.7% 31% 8.66% 6.8% 7.26% 7.3%
ROA (Net income/ Total Assets) 2.75% 2.19% 6.49% 14.7% 4.11% 3.53% 3.87% 3.87%
Assets 1 36,106 21,004 48,573 52,270 30,605 58,418 54,519 49,038
Book Value Per Share 2 39.90 39.30 42.40 50.90 50.60 51.30 53.00 53.50
Cash Flow per Share 2 6.290 5.830 6.800 15.00 10.20 8.590 8.950 8.220
Capex 1 1,728 1,423 1,783 2,438 2,671 2,222 2,153 2,163
Capex / Sales 8.97% 7.1% 6.64% 6.59% 9.51% 8.19% 7.82% 7.54%
Announcement Date 18/02/20 17/02/21 16/02/22 15/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
52.47 USD
Average target price
59.23 USD
Spread / Average Target
+12.87%
Consensus
  1. Stock Market
  2. Equities
  3. NTR Stock
  4. Financials Nutrien Ltd.